Teladoc Health stock: Teladoc Health schedules October 28 results for Teladoc Health stock

Published on 10/24/2026 at 01:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due after the close on October 28, 2026. Teladoc Health stock posted USD 606.93 million revenue for the second quarter, down 4.00 percent.

Revenue pressure and results date

Teladoc Health announced its October 28, 2026 results date on October 14, 2026.
Second-quarter revenue reached USD 606.93 million, down 4.00 percent year over year.
Sixteen brokerages hold a USD 7.54 average target, according to MarketBeat on October 14, 2026.

TDOC, US87918A1051, Illustration mit AI erstellt.

Teladoc Health (ISIN US87918A1051) will release third-quarter 2026 results after the close on October 28, 2026, with second-quarter revenue of USD 606.93 million as the latest operating benchmark. The date was announced on October 14, 2026, by Teladoc Health.

Three events shape the setup

On July 29, 2026, Teladoc Health reported second-quarter revenue of USD 606.93 million, down 4.00 percent year over year, and a loss of USD 0.21 per share, according to MarketBeat. The quarterly loss was narrower than the USD 0.25 consensus loss, while revenue fell short of the USD 615.44 million estimate.

On October 7, 2026, Teladoc Health announced two AI capabilities, SoloVitals and SoloScribe, for its Solo platform serving hospitals and health systems, according to Teladoc Health. On October 14, 2026, the company set October 28, 2026, for its third-quarter release and a 5:00 p.m. ET conference call, according to Teladoc Health.

What does the second-quarter loss mean?

The operating picture combines a shrinking top line with a narrower quarterly loss against consensus. MarketBeat reported a second-quarter net margin of minus 7.13 percent and said full-year 2026 consensus called for a loss of USD 0.92 per share.

That combination makes the October 28 report a test of whether the new Solo tools can support Teladoc Health's hospital business while the broader revenue base remains under pressure. The company operates across virtual medical care, mental health services and chronic-care programs, giving the release several operating areas to address.

Dates for the next report

The next substantiated corporate date is October 28, 2026, when Teladoc Health plans to publish third-quarter results after the market close and hold its conference call at 5:00 p.m. ET. MarketBeat's October 21, 2026 preview put the consensus third-quarter revenue estimate at USD 588.44 million and the expected loss at USD 0.2171 per share.

Stock setup before results

Analyst sentiment remains divided. MarketBeat reported 16 brokerage ratings on October 14, 2026, comprising five Buys, ten Holds and one Sell, with an average 12-month target of USD 7.54. The next report will show whether the AI platform expansion is beginning to change the revenue trend.

The further course of trading is shown by the continuously updated real-time quote of Teladoc Health stock.